Shares of Viveve Medical, Inc. (NASDAQ:VIVE) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that cover the company, Zacks Investment Research reports. Four investment analysts have rated the stock with a strong buy recommendation. Brokers have set a 12 month consensus price target of $13.60 for the […]
